Another study reported that patients with sunitinib-related hypertension showed a twofold increase in plasma endothelin-1 (p-ET-1) [9]; intriguingly, this hypertensive effect did not occur when it was associated with the endothelin-1 (ET-1) receptor inhibitor in rats [10]. The gene discussed is EDN1; the disease is hypertensive disorder.